Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 15, 2022

Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine and Booster in Patients With Autoimmune Rheumatic Diseases

Annals of the Rheumatic Diseases


Additional Info

Annals of the Rheumatic Diseases
BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
Ann. Rheum. Dis 2022 Apr 13;[EPub Ahead of Print], A Bieber, I Sagy, L Novack, S Brikman, R Abuhasira, S Ayalon, I Novofastovski, M Abu-Shakra, R Mader

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading